Stock fact sheet · data as of

LifeStance Health Group, Inc. (LFST): fair value, margin of safety and Wheel Score

Healthcare · Medical - Care Facilities · United States · High Growth

Close12.37
GLS fair value8.218 of 9 models
Margin of safety-51%price above fair value
Wheel Score63Fairout of 100
Health8/9Piotroski F-score
Moat4.4/10GLS 10-year score
Market cap$4.7B3.5M shares a day
Implied vol.55%near-the-money, 20-60 d
P/E93.8EPS 0.13
Dividend yieldnone
Beta1.24moves more than the market
Next earnings5 Nov 2026in 20 days (before the open)

Is LFST undervalued?

LFST closed at 12.37 on 16 Oct 2026, more than 30% above the GLS average fair value of 8.21. Only 2 of the 8 models that produced a value sit above the price. By our models the shares are priced well beyond what the filed earnings, cash flow and book value support; the Sunday Scan drops names like this at the "below fair value" rule.

There is a wide gap between EPV (1.47) and DCF (16.96). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files LFST under High Growth: revenue and earnings growing fast enough that the growth-based models carry the valuation.

Nine valuation models for LFST

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF16.96+37%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number3.38-73%The most a defensive investor pays for the earnings and book value per share
Graham Growth7.55-39%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch3.30-73%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth8.08-35%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap11.93-4%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time13.06+6%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV1.47-88%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-0.6979-106%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target14.14+14%Analysts' average 12-month price target. Not in the average

Quality and financial health

LifeStance Health Group, Inc. scores 8 of 9 on the Piotroski F-score, the nine yes/no tests of profitability, leverage and efficiency on the latest annual accounts - a strong reading that passes the Sunday Scan's "6 or more" rule with room to spare. A GLS Moat score of 4.4/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC 0.6%, ROE 0.6%, ROA 0.4% - with debt at 0.13 times equity and a free-cash-flow yield of 4.4%.

LifeStance Health Group, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.

Institutional ownership scores 10/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score8 / 9ROIC0.6%
GLS Moat4.4 / 10ROE0.6%
Debt / equity0.13ROA0.4%
Free-cash-flow yield4.4%Payout ratio0%
Institutions10 / 10Insiders · Congress1 · 5 / 10

Wheel Score 63: Fair

A Wheel Score of 63 puts LifeStance Health Group, Inc. in the Fair band - below the 70 the Sunday Scan requires. Value 0/25, Health 18/20, Moat 7/15, Premium 20/20 and Stability 19/20; the weakest part is Value (0/25).

Implied volatility is 55% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. Chain open interest is 10,251 contracts across all expiries - enough for the wheel at normal size.

Volume runs at 3.5M shares a day on a market cap of $4.7B, with a beta of 1.24 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 19 of 20.

PartPointsFrom
Value0 / 25-51% margin of safety
Health18 / 20Piotroski 8/9
Moat7 / 15moat 4.4/10
Premium20 / 20implied volatility 55%
Stability19 / 203.5M shares/day, $4.7B cap, beta 1.24

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 5 Nov 2026 (before the open), 20 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Care Facilities

The 12 companies below are the closest to LifeStance Health Group, Inc. by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
OPCH
Option Care Health, Inc.
31.2236.30+14%70Good$4.7B
CON
Concentra Group Holdings Parent, Inc.
39.1528.17-39%66Good$5.0B
NHC
National HealthCare Corporation
245.53259.14+5%75Good$3.8B
HIMS
Hims & Hers Health, Inc.
29.3855.91+47%45Weak$6.6B
CHE
Chemed Corporation
515.44334.59-54%58Fair$6.7B
PACS
PACS Group, Inc.
44.9856.37+20%82Prime$7.1B
ACHC
Acadia Healthcare Company, Inc.
31.0416.57-87%45Weak$2.9B
AVAH
Aveanna Healthcare Holdings Inc.
12.6425.89+51%77Good$2.8B
GRDN
Guardian Pharmacy Services, Inc.
39.6829.13-36%58Fair$2.5B
BKD
Brookdale Senior Living Inc.
10.098.23-23%45Weak$2.4B
MD
Pediatrix Medical Group, Inc.
27.7634.92+21%78Good$2.3B
ADUS
Addus HomeCare Corporation
116.49115.55-1%67Good$2.2B

⚖ Compare LFST with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about LFST

Is LFST undervalued right now?

No: at 12.37 the stock trades 51% above the GLS average fair value of 8.21 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of LFST and what does it mean?

LFST scores 63 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.

What is the GLS fair value for LFST?

8.21 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does LifeStance Health Group, Inc. report earnings next?

The next earnings report is due on 5 Nov 2026 (before the open), 20 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does LFST have listed options, and how liquid are they?

Yes. The nightly snapshot found 210 listed contracts with 10,251 open interest across all expiries and implied volatility of 55% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.